Looking for a way to play the impending bounce in gold prices? You should be, and you should be looking at Nexus Gold Corp. (OTCMKTS:NXXGF, CVE:NXS) in particular. This junior gold miner is gelling at the exact right time, for all the right reasons.
First and foremost, gold prices are on the verge of bounce, largely driven by an impending pullback of the overextended U.S. dollar.
A comparison of the SPDR Gold Trust ETF (NYSEARCA:GLD) versus the U.S. Dollar Index tells the tale. GLD fell 11% between September and last week’s low, in (inverse) step with the 6.7% advance the U.S. dollar made during that time… a huge move by currency standards. The dollar’s rally was predicated on the likelihood of rising interest rates, but now that the dust has settled, traders are starting to realize they overshot. Today’s 0.37% pullback from the dollar is the biggest pullback we’ve seen in weeks, suggesting the pendulum is swinging the other way.
Top 10 Heal Care Stocks To Own For 2017: Monro Muffler Brake, Inc.(MNRO)
- [By Ben Levisohn]
Yesterday, shares of Monro Muffler Brake (MNRO) plunged 3.1% after Barron’s Leslie Norton panned the stock in this weekend’s issue of the magazine. And wouldn’t you know it? Monro’s shares are skidding lower once again today.
Norton’s argument was straightforward:
At a recent $62, Rochester, N.Y.based Monro (ticker: MNRO) trades at a lofty 28 times forward earnings, compared with a 10-year average of 21.1, and 17 times earnings for the Standard & Poors 500. With sales growth slowing as competition increases, Monros strategic goal of achieving 15% annual sales gains and 20% profit growth seems distant.
Any hint of more sluggish sales could push the shares down at least 10%. Bruce Geller, CEO of money manager Dalton Greiner Hartman Maher, who is short the stock, says, A fairly commoditized business with low organic growth deserves a more reasonable multiple of 20 times.
That would put the stock in the mid-$40s.
Shares of Monro Muffler Brake have dropped 4% to $57.59 at 3:49 p.m. today, leaving around 20% of downside.
UPDATE: This post initially misspelled ‘Brake’ as ‘Break.’ It’s been corrected.
Top 10 Heal Care Stocks To Own For 2017: Crestwood Equity Partners LP(CEQP)
- [By Lisa Levin]
Crestwood Equity Partners LP (NYSE: CEQP) shares shot up 45 percent to $18.54 following the announcement of a new joint venture with Consolidated Edison, Inc. (NYSE: ED). Subsidiaries of both companies entered into an agreement on Thursday to form a joint venture in which they will jointly own and develop Crestwood’s existing natural gas pipeline and storage business in norther Pennsylvania and southern New York.
Top 10 Heal Care Stocks To Own For 2017: ConocoPhillips(COP)
- [By Sankalp Soni]
For the first time in eight years, OPEC has decided to cut oil production. The announcement has sent crude oil rallying 10 percent higher since, and led to a rally across the board in Chevron Corporation (NSYE: CVX), Exxon Mobile Corporation (NYSE: XOM), BP plc (ADR) (NYSE: BP) ConnocoPhillips (NYSE: COP) and the United States Brent Oil Fund LP (ETF) (NYSE: USO).
- [By Tyler Crowe]
Also, to comound these problems, there isn’t a clear leader of the project that can steer its investment deicisions. ExxonMobil (NYSE: XOM ) , Royal Dutch Shell (NYSE: RDS-A ) , Eni (NYSE: E ) , Total (NYSE: TOT ) , and Kazakh national oil company KazMunaiGas each have a16.81% working interest in the project. This has led to problems involving investment decisions and project mangement.BothExxonMobilandRoyal Dutch Shellhave been extremelydisappointedwith the results, to the point that they have threatened to pull out of the project altogether on a couple of occasions, andConocoPhillips (NYSE: COP ) did get out this year by selling its $5 billion stake in the project to China National Petroleum.
- [By Wayne Duggan]
Bernstein maintains Outperform ratings on the following oil stocks:
Apache Corporation (NYSE: APA) Anadarko Petroleum Corporation (NYSE: APC) Cobalt International Energy, Inc. (NYSE: CIE) Cabot Oil & Gas Corporation (NYSE: COG) ConocoPhillips (NYSE: COP) Devon Energy Corp (NYSE: DVN) EOG Resources Inc (NYSE: EOG) Range Resources Corp. (NYSE: RRC) Southwestern Energy Company (NYSE: SWN)
GMP analyst Bob Bakanauskas went long E&Ps back on February 3. He predicts that the oil market will transition from oversupply to undersupply in 2017. From that point forward, the world will once again require shale production growth.
- [By Lisa Levin]
ConocoPhillips (NYSE: COP) reported weaker-than-expected results for its fourth quarter.
ConocoPhillips said that it lost $0.90 per share in the fourth quarter on revenue of $6.77 billion. Wall Street analysts were expecting the company to lose $0.52 per share on revenue of $9.08 billion.
Top 10 Heal Care Stocks To Own For 2017: NGL ENERGY PARTNERS LP(NGL)
- [By Lisa Levin]
On Friday, the energy sector proved to be a source of strength for the market. Leading the sector was strength from NGL Energy Partners LP (NYSE: NGL) and Legacy Reserves LP (NASDAQ: LGCY).
Top 10 Heal Care Stocks To Own For 2017: Biotricity (BTCY)
- [By Peter Graham]
Sandhill.com recently interviewed the chairman, CEO and founder Waqaas Al-Siddiq small cap wearables stock Biotricity (OTCQB: BTCY) about how wearables benefit patients, integrate into healthcare systems and improve treatment compliance as well as how the cloud and the Internet of Things impact the medical wearables space. biotricitys is a medical technology company focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. biotricitys R&D focuses on the preventative healthcare market, with a vision of putting health management into the hands of the individual by supporting the self-management of critical and chronic conditions.
- [By Matthew Briar]
Last week, medical technology developer Biotricity Inc. (OTCMKTS:BTCY) announced that part of its heart-monitoring hardware received the necessary 501k clearance from the Food & Drug Administration. It was a not-so-gentle reminder that the company is nearing the end of the R&D journey with its bioflux device, which provides caregivers round-the-clock monitoring of a heart patient’s vital stats. BTCY could have the device on the market within a matter of weeks, putting the organization into a multi-billion dollar market with a platform like no other.
And yet, heart-monitoring is only going to be a part of what the company does.
Today’s news was a not-so-gentle reminder of that a well…. Biotricity Inc. is already eyeing the entry into other markets aside from the cardiac market that would benefit from remote monitoring.
One has to back-track to the September 29th press release to set the stage. That’s when the company announced it would take the same basic remote-monitoring technology and apply it to fetal monitoring and sleep apnea, at least. The way the PR read left open the possibility to even more medically-related uses.
For some it may have been a read-it-and-forget-it affair. Lots of companies announce their intentions, and then get around to doing it whenever they feel like it, IF they feel like it. Biotricity wasn’t just blowing smoke though. Today, the company announced that its primary development partner — the University of Calgary — and it hammered out specific plans to create ‘remote monitoring mobile devices in a number of clinical settings, including peri-operative medicine, maternal/fetal medicine and acute and chronic care medicine in order to facilitate the application of “smart” medical grade wearables to the hospital and out-patient settings.’
This second mention of the idea suggests it’s going to happen sooner than later, even as the company continues to push bioflux towards commercializ
- [By James E. Brumley]
These are two of the key stumbling blocks Fitbit hit, and the two big stumbling blocks Biotricity Inc (OTCMKTS:BTCY) has completely sidestepped.
For the unfamiliar, Biotricity is the developer of two different but related wearable, 24/7 heart monitoring technologies. The device called bioflux is for use by caregivers in a clinical setting, remotely transmitting detailed information about the heart’s functioning which can then be analyzed by caregivers. The device known as biolife serves individuals outside of a clinical setting, largely doing the same chore. The advantage of the technology is mobility, without sacrificing accuracy.
- [By Matthew Briar]
Biotricity Inc (OTCMKTS:BTCY) announced on Tuesday morning it was teaming up with Global to Local (G2L) to develop remote monitoring solutions that not only work, but serve the underserved (medically speaking) community. This partnership is of particular interest to current and would-be BTCY investors, as it will likely validate the crux of the work the company has done thus far.
Biotricity is the developer of two different though related technologies. One is called bioflux, and the other is called biolife. Both are heart-monitoring devices… the former for use by caregivers in a clinical setting, while the latter is for use by individuals outside of a clinical setting. Neither is on the market yet, but both are projected to be on the market next year. The company recently filed a 510k request with the FDA for its bioflux technology (the 510k path is for medical devices rather than drugs, and as such doesn’t require a lot of regulatory deliberation), and has heard back from the FDA about a key part of the device already – it got the green light. Another arm of the FDA must look at other aspects of the device.
The technology is unique, in that it not only provides stunningly accurate detailed information about a patient’s heart function, but it constantly feeds that data – remotely – to a caregiver and monitor that can make good use of that data. In August the company announced AT&T Inc. (NYSE:T) would be handling the wireless (cellular) connectivity between clinics and patients’ bioflux devices.
It’s a breakthrough, for many reasons, not the least of which is that remote monitoring lowers overall healthcare costs for those patients, and ultimately, for insurers.
The hardware is not yet available on a commercial basis, but it is being tested in a clinical setting. The Global to Local partnership will be another field test of sorts, validating the work Biotricity has performed on the R&D front.
The organization says
Top 10 Heal Care Stocks To Own For 2017: Arcadia Biosciences, Inc.(RKDA)
- [By Jim Robertson]
Yesterday, our Under the Radar Movers newsletter suggested small cap agricultural biotechnology Arcadia Biosciences (NASDAQ: RKDA) as a short/bearish trade:
- [By Peter Graham]
The Q3 2016 earnings report formid cap pet stock agricultural biotechnology Arcadia Biosciences (NASDAQ: RKDA) is scheduled for after the market closes onThursday (November 10th). Last Thursday, our Under the Radar Movers newsletter suggestedthe stockas a short/bearish trade, saying:
Top 10 Heal Care Stocks To Own For 2017: ClubCorp Holdings, Inc.(MYCC)
- [By Steve Symington]
Shares of ClubCorp Holdings Inc. (NYSE:MYCC) jumped 15.7% Thursday after reports stating the private golf and country-club specialist is considering strategic alternatives.
Top 10 Heal Care Stocks To Own For 2017: Perceptron, Inc.(PRCP)
- [By Lisa Levin]
Perceptron, Inc. (NASDAQ: PRCP) shares shot up 14 percent to $7.23. Perceptron reported Q2 earnings of $0.27 per share on revenue of $21.75 million.
Top 10 Heal Care Stocks To Own For 2017: Veeco Instruments Inc.(VECO)
- [By WWW.GURUFOCUS.COM]
VECO (NASDAQ:VECO) contributed 1.16% to the Fund’s quarterly return, nearly equaling AAN’s contribution in the quarter. VECO appreciated over 48% in the quarter due to an acceleration of orders for its key MOCVD tools. These tools are the main manufacturing equipment used to produce LEDs, whether they are for display screens or, increasingly, for lighting products. We estimate that VECO currently has roughly 80% global market share for MOCVD tools used to make LEDs.
Top 10 Heal Care Stocks To Own For 2017: Ishares Trust Dj Us Financial (IYF)
- [By Wayne Duggan]
Investors looking to set up a pair trade to capitalize on the divergent paths of U.S. and European banks should consider going long the iShares Dow Jones US Financial (ETF) (NYSE: IYF) and short the Ishares MSCI Europe Fincls Sctr Indx Fd (NASDAQ: EUFN).